Кафедра внутренних болезней ИМПЗ

Medicine & Life Sciences

1. Mason-Type Diabetes 100%
2. Pulmonary Surfactant-Associated Protein D 95%
3. Photochemotherapy 94%
4. Photosensitizing Agents 93%
5. Pulmonary Surfactant-Associated Protein A 78%
6. Methylene Blue 77%
7. Lasers 72%
8. bremachlorin 64%
9. Cytochrome P-450 CYP2C19 60%
10. Tuberculous Empyema 58%
11. Russia 55%
12. Coronary Artery Disease 54%
13. Pneumonia 53%
14. phytochlorin 52%
15. Surface-Active Agents 51%
16. SARS Virus 48%
17. Proprotein Convertase 9 48%
18. Hyperammonemia 44%
19. Scientific Societies 42%
20. Bifidobacterium 41%
21. Mycobacterium tuberculosis 39%
22. Gastroenterologists 39%
23. Treatment Adherence and Compliance 37%
24. Coronary Vessels 35%
25. Gonadal Steroid Hormones 35%
26. Probiotics 35%
27. Genes 34%
28. Glucose 33%
29. Acute Coronary Syndrome 33%
30. Adenosine Diphosphate 32%
31. Microbiota 32%
32. Pharmaceutical Preparations 32%
33. Multiple Myeloma 32%
34. Gastrointestinal Microbiome 32%
35. Cardiovascular Diseases 32%
36. Confocal Microscopy 31%
37. Anticoagulants 30%
38. Insulin 30%
39. Atrial Fibrillation 29%
40. Diabetes Mellitus 29%
41. In Vitro Techniques 28%
42. Antiviral Agents 28%
43. Calcium 28%
44. Platelet Activation 27%
45. Skin 27%
46. Light 26%
47. Smoking 26%
48. Chronic Disease 26%
49. Epidemiology 25%
50. Blood Platelets 25%
51. Hypertension 25%
52. Observation 25%
53. Software 24%
54. Data Analysis 24%
55. Infections 23%
56. Therapeutics 22%
57. Fatty Liver 21%
58. Radiation 20%
59. Mutation 20%
60. Liver 20%
61. Fluorescence 20%
62. Safety 19%
63. Recurrence 18%
64. P(2)-(1-(2-nitrophenyl)ethyl) ADP 18%
65. Bacteroidetes 17%
66. Firmicutes 17%
67. Cytochrome P-450 CYP2C9 17%
68. Blood Glucose 17%
69. Proteins 16%
70. Liver Diseases 16%
71. Cytochrome P-450 CYP2D6 16%
72. Siberia 16%
73. Rivaroxaban 15%
74. Phototoxic Dermatitis 15%
75. Fistula 14%
76. aluminum phthalocyanine 14%
77. Testosterone 14%
78. Transaminases 13%
79. Molecular Biology 12%
80. Blood Pressure 12%
81. apixaban 12%
82. Veillonellaceae 12%
83. Hyperglycemia 12%
84. Growth 11%
85. Dabigatran 11%
86. Incidence 11%
87. Lung 11%
88. Bacteroidaceae 11%
89. Pulmonary Surfactants 11%
90. Satellite Hospitals 11%
91. Purinergic P2 Receptors 11%
92. Atrial Flutter 11%
93. Inhibitory Concentration 50 11%
94. Pathology 10%
95. Skin Diseases 10%
96. Empyema 10%
97. Sanitation 10%
98. Alleles 10%
99. Vero Cells 10%